المؤلفون: Riyam Qusay Ibrahim Al-Jadir, Jaffar Nouri Alalsaidissa

المصدر: Iraqi Journal of Hematology, Vol 9, Iss 2, Pp 131-137 (2020)

مصطلحات موضوعية: chronic myelogenous leukemia, t315i mutation, tyrosine kinase inhibitor resistance, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://www.ijhonline.org/article.asp?issn=2072-8069;year=2020;volume=9;issue=2;spage=131;epage=137;aulast=Al-Jadir; https://doaj.org/toc/2072-8069

URL الوصول: https://doaj.org/article/70432d0f80b24c7aadaf0bbebe84f091

المؤلفون: Jaffar N. Jaffar Alalsaidissa, Riyam Qusay Ibrahim Al-Jadir

المصدر: Iraqi Journal of Hematology, Vol 9, Iss 2, Pp 131-137 (2020)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.drug_class, Tyrosine-kinase inhibitor, law.invention, symbols.namesake, law, Internal medicine, hemic and lymphatic diseases, medicine, Polymerase chain reaction, Sanger sequencing, ABL, business.industry, lcsh:RC633-647.5, t315i mutation, Myeloid leukemia, tyrosine kinase inhibitor resistance, lcsh:Diseases of the blood and blood-forming organs, medicine.disease, chronic myelogenous leukemia, Mutation (genetic algorithm), symbols, business, Tyrosine kinase, Chronic myelogenous leukemia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6ffa2f798601d825e6c2d849a5a2f5
http://www.ijhonline.org/article.asp?issn=2072-8069;year=2020;volume=9;issue=2;spage=131;epage=137;aulast=Al-Jadir